Webinar: Modernization and Accessibility of Clinical Research by Implementing Decentralized Clinical Trials as a Care Option for Participants

MARK YOUR CALENDARS for Tuesday, July 13th; 12:00 pm - 1:00 pm, and share this news with your colleagues!

Topic: In the era of clinical research modernization and accessibility with equity, this webinar will address the multiple strategic and operational dimensions involved in Decentralized Clinical Trials (DCTs), including the concept and principles of Clinical Research as a Care Option (CRAACO).  Synergies that exist between DCTs, CRAACO and standard health care systems will be discussed.  The adoption of fit-for-purpose technology for DCTs applying CRAACO will also be explored as well as ways of enhancing trial participants experience and including diversity in DCTs applying CRAACO compared to traditional trials.

Registration will be open from June 11 to July 09, 2021.

*Registrants may be substituted, but no refunds will be issued after the deadline. 
*Disclaimer: CAPRA reserves the right to make amendments to the conference (including but not limited to speakers' identity, topics, locations, the timing of speakers) without notice to you. If the conference is cancelled for any reason whatsoever, such reason not within the control of CAPRA, CAPRA shall not be liable for any cost or loss otherwise incurred.

Event Registration Form: Please add your First name, Last name and the Email address that you will use to log in the day of the webinar. 
Be sure to check system requirements to avoid any connection issues the day of the event. 
In case of unexpected interruptions such as a power outage please log back, and the webinar will restart  from where it was disconnected.

Speakers / Panelists

• 

  Dr. Isaac R. Rodriguez-Chavez

  PhD, MHS, MS, Senior Vice President, Scientific and Clinical Affairs & Head, Global Center of Excellence Strategy for Decentralized Clinical Trials

  Dr. Isaac R. Rodriguez-Chavez

  ×

  

  PhD, MHS, MS, Senior Vice President, Scientific and Clinical Affairs & Head, Global Center of Excellence Strategy for Decentralized Clinical Trials

  ICON plc

  Dr. Isaac Rodriguez-Chavez is a biomedical leader with expertise in Infectious Diseases (Viral Immunology, Viral Oncology, Microbiology), Immunology, and Vaccinology.  His expertise spans basic, translational, pre-clinical and clinical research (phase I – IV global trials).  He also has expertise in digital health technologies, modern clinical research development and operations, regulatory affairs, approval or licensure of medical products, and quality control and quality assurance.
  Dr. Rodriguez-Chavez joined PRA Health Sciences as a Senior Vice President for Scientific and Clinical Affairs, leading the Strategy of PRA’s Global Center of Excellence for Decentralized Clinical Trials (DCTs) using Digital Health Technologies (DHTs). He also has other executive leadership roles across the organization that deal with scientific and medical affairs.  
  Overall, Dr. Rodriguez-Chavez has over 32 years of work experience in several national and international organizations, including the U.S. Food and Drug Administration (FDA), National Institute of Health (NIH), industry and non-profit research organizations.  Recently, he worked at the FDA, Center for Drug Evaluation and Research (CDER) as a Senior Officer for Clinical Research Methodologies, Regulatory Compliance and Medical Policy Development.  He led FDA policy development work on DCTs using DHTs, and he was directly involved in programs for the modernization of clinical research that impact multiple disease areas.  
  Other past positions he held included CEO and Founder of a biomedical consulting firm, 4Biosolutions Consulting; Vice President for Research, Texas Biomedical Research Institute; Director of the AIDS and Immunosuppression Program, National Institute of Dental and Craniofacial Research (NIDCR), NIH; Senior Clinical Scientist, Schering Plough Corporation; Director of Portfolio for HIV Vaccine Programs, National Institute of Allergy and Infectious Diseases (NIAID), NIH; Scientist at St. Luke’s/Roosevelt Hospital, Columbia University; Lead Scientist, Polar Biotechnology Company (Venezuela); and Scientist in Viral Immunology, Venezuelan Institute for Scientific Research, IVIC.
  He issued the first U.S. Good Clinical Laboratory Practice (GCLP) Guidelines to improve the consistency of clinical laboratory endpoints supporting trials globally, published numerous scientific and technical articles, and has been an invited speaker in 95 global conferences.  He has a B.S. in Biology (Venezuela), M.S. in Microbiology (Venezuela), M.H.S. in Clinical Research (Duke School of Medicine), and a Ph.D. in Virology and Immunology (University of Delaware).  He did two post-doctoral specialty trainings in Viral Immunology and Viral Oncology combined with Clinical Research at the National Institute on Aging (NIA) and the National Cancer Institute (NCI) at NIH.   
  Dr. Rodriguez-Chavez is a Board Member of the Scientific Leadership of the Digital Medical Society (DiME).  He is also a co-chair of the DiME’s Research Committee, driving digital medicine globally.  He is a regulatory Advisor and Vice-Chair of the Institute of Electrical and Electronics Engineers (IEEE) fostering initiatives on DCTs and DHTs.  He is a Leadership Council member of the Decentralized Trials & Research Alliance (DTRA) and he is a board member of the Hypertrophic Cardiomyopathy Association (HCMA).  He is a global content editor for regulatory science at the DIA Global Forum Magazine.  He is also an active member is fourteen professional associations, including the American Association of Immunologists, American Society for Virology, American Society of Microbiology, Society of Quality Assurance, Association of Clinical Research Professionals, New York Academy of Sciences, International AIDS Society, International Association for Dental Research, American Association for Dental Research, and Regulatory Affairs Professional Society. 

  LinkedIn: https://www.linkedin.com/in/isaacrc/ 

Registration is now closed